- BioNTech SE and Moderna Inc. are adjusting their COVID-19 vaccines to fight the omicron variant. BioNTech said it could have a new version of its shot ready within 100 days. The drugmakers are starting development as research continues on whether new shots are needed at all. (Articles here and here)
November 29, 2021
Life Sciences